BeStock  

Dentsply Sirona XRAY

US equityMarket cap rank #2811Medical Instruments & Supplies
$8.29 −$0.20 (-2.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.34 +0.60%
Open$8.45
Prev close$8.49
Day range$8.24 – $8.74
Volume4.88M
Market cap$1.64B
P/E (TTM)–
Dividend yield1.93%

Earnings

Average move on report day±8.4%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+16.3%
Worst reaction-28.0%

Stock move on the day after each report

-1.9%2023/Q4-6.0%2024/Q1+1.3%2024/Q2-28.0%2024/Q3-8.8%2024/Q4+16.3%2025/Q1-3.3%2025/Q2-12.7%2025/Q3+15.5%2025/Q4-2.0%2026/Q1-8.0%2026/Q2-6.2%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026After Market±11.9%-6.24%Within range
2026/Q26 Aug 2026After Market±11.6%-7.97%Within range
2026/Q15 May 2026After Market±16.3%-2.02%Within range
2025/Q426 Feb 2026After Market±11.3%+15.50%Bigger than priced
2025/Q36 Nov 2025Pre Market±12.9%-12.68%Within range
2025/Q27 Aug 2025Pre Market±22.2%-3.29%Within range
2025/Q18 May 2025Pre Market±17.0%+16.30%Within range
2024/Q427 Feb 2025None±16.3%-8.83%Within range
2024/Q37 Nov 2024Pre Market±11.2%-28.02%Bigger than priced
2024/Q231 Jul 2024Pre Market±12.6%+1.34%Within range
2024/Q12 May 2024Pre Market±6.9%-5.96%Within range
2023/Q429 Feb 2024None±10.3%-1.86%Within range
2023/Q32 Nov 2023Pre Market±7.3%-7.46%Bigger than priced
2023/Q23 Aug 2023Pre Market±9.7%-3.42%Within range
2023/Q13 May 2023Pre Market±11.3%-3.85%Within range
2022/Q428 Feb 2023Pre Market±7.7%+10.19%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Essential Dental Solutions$343.00M 41.0%
  • Connected Technology Solutions$230.00M 27.5%
  • Orthodontic and Implant Solutions$171.00M 20.5%
  • Wellspect Healthcare$92.00M 11.0%

Latest reported quarter: Q3, ended Sep 2026

Revenue$836.00M-7.5% YoY
Operating profit$37.00M-19.6% YoY
Net profit-$3.00M+99.3% YoY
Diluted EPS-$0.01+99.5% YoY
Free cash flow$0.00-100.0% YoY
Operating cash flow$32.00M

Revenue, last 8 quarters

$905.0MDec '24$879.0MMar '25$936.0MJun '25$904.0MSep '25$961.0MDec '25$880.0MMar '26$898.0MJun '26$836.0MSep '26

Net profit, last 8 quarters

$-428.0MDec '24$19.0MMar '25$-44.0MJun '25$-428.0MSep '25$-145.0MDec '25$-10.0MMar '26$36.0MJun '26$-3.0MSep '26

Profitability & balance sheet

Gross margin50.5%
Operating margin4.9%
Net margin-3.4%
Return on equity-8.5%
Return on assets-2.2%
Return on invested capital-1.7%
Current ratio1.63
Liabilities / assets73.9%
Cash & investments$195.00M
Total debt$2.29B
Net cash (debt)-$2.09B
Free cash flow / sales2.9%

Discussion

No comments yet — be the first to weigh in on XRAY.

Sign in to join the discussion.

Scroll to Top